Clinical Trial Update: Safety and Efficacy Study of Mesenchymal Stem Cell in Treating Kidney Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on the safety and efficacy of mesenchymal stem cell therapy for kidney fibrosis in a Phase 1/2 study conducted by Nanjing Medical Univer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Fibrosis
• Renal Cirrhosis

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Nanjing Medical University | Conditions: Renal Cirrhosis | Phase 1, Phase 2 | Status: UNKNOWN